UNSPSC 51383302: Aceclofenac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H13Cl2NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RPK779R03H, chemically known as 2-(o-(2,6-dichloranilino)phenylacetoxy)essigsaeure but generally known as aceclofenac, which bears US NIH Compound Identifier 71771. European Medicines Agency schedules Aceclofenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05200MIG.

UNSPSC 51383302 Aceclofenac is a Commodity code for a nonsteroidal anti-inflammatory drug (NSAID) used in pain and inflammation management. However, the recent state and local solicitation activity tagged to this code shows a mismatch: Seminole County, Florida posted an IFB for Naloxone and Safe Drug Deactivation Systems, neither of which are aceclofenac or related pharmaceutical products. The county is procuring 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding to support community health initiatives, with quarterly deliveries required to the Seminole County Community Health Building in Sanford. This code shows little relevant recent activity aligned with its nominal scope.

The sole recent opportunity under this code is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023. Vendors must submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposals, and meet E-Verify compliance and drug-free workplace certification requirements. The contract carries a two-year initial term with an optional one-year renewal, includes a three-month probationary period, and specifies workers' compensation, commercial general liability, and professional liability insurance. The procurement is potentially FEMA-funded and subject to federal environmental compliance standards.